Slideshow
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
-
Slide
This slideshow reviews drug information for OPDIVO (nivolumab), indicated for metastatic squamous non-small cell lung cancer (NSCLC).
Table of Contents
Slide 3: Indication, Dosage, and AdministrationSlide 8: Use in Specific PopulationsSlide 10: Clinical PharmacologySlide 14: Warnings and PrecautionsSlide 18: Clinical Safety and EfficacySlide 27: Drug Storage and SupplySlide 29: References